China SXT Pharmaceuticals (SXTC) Assets Average (2018 - 2026)
China SXT Pharmaceuticals (SXTC) posted quarterly Assets Average of $30.6 million for Q1 2026, up 16.04% year-over-year from $26.3 million in Q1 2025, and up 27.26% quarter-over-quarter from $24.0 million in Q3 2025.
China SXT Pharmaceuticals (SXTC) Assets Average (2018 - 2026) Analysis & Trends
China SXT Pharmaceuticals' Assets Average history runs 9 years deep, the most recent figure standing at $30.6 million for Q1 2026.
- In Q1 2026, Assets Average rose 16.04% year-over-year to $30.6 million; the TTM figure through Mar 2026 stood at $30.6 million (up 16.04% YoY), while the FY2026 annual figure was $28.2 million, up 25.96% from the prior year.
- Assets Average for Q1 2026 stood at $30.6 million, up from $24.0 million in the prior quarter.
- The five-year high for Assets Average was $30.6 million in Q1 2026, with the low at $18.9 million in Q1 2024.
- The 5-year median for Assets Average is $26.3 million (2025), against an average of $25.6 million.
- The sharpest annual moves came in 2024 and 2025: Assets Average decreased 27.1% in 2024, then jumped 39.63% in 2025.
- China SXT Pharmaceuticals' Assets Average stood at $27.9 million in 2022, then slipped by 20.79% to $22.1 million in 2023, then gained by 22.61% to $27.1 million in 2024, then declined by 11.28% to $24.0 million in 2025, then gained by 27.26% to $30.6 million in 2026.
- Business Quant data shows SXTC's Assets Average at $30.6 million in Q1 2026, $24.0 million in Q3 2025, and $26.3 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 5.97 Bn |
| 10 | China SXT Pharmaceuticals | 32,442.83 | -28.14 Mn | - | 30.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.55 Mn |
| Sep 30, 2025 | 24.01 Mn |
| Mar 31, 2025 | 26.33 Mn |
| Sep 30, 2024 | 27.06 Mn |
| Mar 31, 2024 | 18.86 Mn |
| Sep 30, 2023 | 22.07 Mn |
| Mar 31, 2023 | 25.87 Mn |
| Sep 30, 2022 | 27.86 Mn |
| Mar 31, 2022 | 28.11 Mn |
| Sep 30, 2021 | 28.61 Mn |
| Mar 31, 2021 | 29.30 Mn |
| Sep 30, 2020 | 22.87 Mn |
| Mar 31, 2020 | 22.37 Mn |
| Sep 30, 2019 | 20.26 Mn |
| Mar 31, 2019 | 12.71 Mn |
| Sep 30, 2018 | 7.80 Mn |